These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


405 related items for PubMed ID: 16716151

  • 1. The impact of immunosuppression on erythema migrans. A retrospective study of clinical presentation, response to treatment and production of Borrelia antibodies in 33 patients.
    Fürst B, Glatz M, Kerl H, Müllegger RR.
    Clin Exp Dermatol; 2006 Jul; 31(4):509-14. PubMed ID: 16716151
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Lymphoproliferative responses to Borrelia burgdorferi in patients with erythema migrans, acrodermatitis chronica atrophicans, lymphadenosis benigna cutis, and morphea.
    Buechner SA, Lautenschlager S, Itin P, Bircher A, Erb P.
    Arch Dermatol; 1995 Jun; 131(6):673-7. PubMed ID: 7778918
    [Abstract] [Full Text] [Related]

  • 6. No detection of Borrelia burgdorferi-specific DNA in erythema migrans lesions after minocycline treatment.
    Muellegger RR, Zoechling N, Soyer HP, Hoedl S, Wienecke R, Volkenandt M, Kerl H.
    Arch Dermatol; 1995 Jun; 131(6):678-82. PubMed ID: 7778919
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Evaluation of immunofluorescence test (IFT) and immuno (western) blot (WB) test in patients with erythema migrans.
    Ruzić-Sabljić E, Maraspin V, Cimperman J, Lotric-Furlan S, Strle F.
    Wien Klin Wochenschr; 2002 Jul 31; 114(13-14):586-90. PubMed ID: 12422606
    [Abstract] [Full Text] [Related]

  • 10. Erythema migrans in solid-organ transplant recipients.
    Maraspin V, Cimperman J, Lotric-Furlan S, Logar M, Ruzić-Sabljić E, Strle F.
    Clin Infect Dis; 2006 Jun 15; 42(12):1751-4. PubMed ID: 16705583
    [Abstract] [Full Text] [Related]

  • 11. Development of erythema migrans in spite of treatment with antibiotics after a tick bite.
    Maraspin V, Lotric-Furlan S, Strle F.
    Wien Klin Wochenschr; 2002 Jul 31; 114(13-14):616-9. PubMed ID: 12422612
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Multilocular erythema migrans in borreliosis].
    Krischer S, Ott H, Barker M, Frank J, Erdmann S.
    Klin Padiatr; 2004 Jul 31; 216(4):236-7. PubMed ID: 15284948
    [Abstract] [Full Text] [Related]

  • 18. Long-term prognosis in patients treated for erythema chronicum migrans and acrodermatitis chronica atrophicans.
    Hulshof MM, Vandenbroucke JP, Nohlmans LM, Spanjaard L, Bavinck JN, Dijkmans BA.
    Arch Dermatol; 1997 Jan 31; 133(1):33-7. PubMed ID: 9006370
    [Abstract] [Full Text] [Related]

  • 19. Lyme disease in children in southeastern Connecticut. Pediatric Lyme Disease Study Group.
    Gerber MA, Shapiro ED, Burke GS, Parcells VJ, Bell GL.
    N Engl J Med; 1996 Oct 24; 335(17):1270-4. PubMed ID: 8857006
    [Abstract] [Full Text] [Related]

  • 20. Diagnosis, treatment, and prognosis of erythema migrans and Lyme arthritis.
    Feder HM, Abeles M, Bernstein M, Whitaker-Worth D, Grant-Kels JM.
    Clin Dermatol; 2006 Oct 24; 24(6):509-20. PubMed ID: 17113969
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.